Based on the importance of PI3K/Akt signaling and the deregulation of class IA PI3K isoforms, especially PI3K p110α, we investigated the potential of pharmacological inhibition of theses isoforms in GBM cell proliferation. This evidence concerns the gene AKT1 and glioblastoma.